Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Cancer of unknown primary: how did we get here?

Tony Greco • 9 Jun 2020
ASCO 2020
General

Tony Greco, MD, Tennessee Oncology, Nashville, TN, outlines the current understanding and management of patients with cancer of unknown primary site (CUP). Advancements in adequately diagnosing the occult primary cancer or tissue of origin have occurred with the use of panels of immunocytochemistry and molecular profiling assays. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Tony Greco

3:55
Redefining cancer of unknown primary
Tony Greco • 9 Jun 2020
1:42
ADAURA: the benefit of adjuvant osimertinib
Tony Greco • 9 Jun 2020

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals